Stockreport

Humacyte Shares Drop 19% After Proposed Public Offering News [MarketWatch]

Humacyte, Inc.  (HUMA) 
PDF In late trading, the stock had declined 19% to trade at $3.49. Shares closed the day's regular session with a 1.1% loss, to finish at $4.35. Advertisement The biote [Read more]